围术期脑脊液引流不增加胸主动脉及开窗腔内主动脉修复术后静脉血栓栓塞风险
单中心连续纳入2011—2020年行胸主动脉腔内修复或开窗腔内主动脉修复(TEVAR/FEVAR)的897例患者,43%(387例)曾放置脑脊液引流(CSFD)。总体静脉血栓栓塞(VTE)发生率为2.2%(20例);CSFD组VTE发生率1.8%,非CSFD组为3.5%(比值比0.70,95%CI 0.28-1.78,P=0.300)。结论认为CSFD放置与VTE风险升高无关,择期外手术及围术期经过复杂者VTE风险更高,治疗性CSFD者VTE风险高于预防性CSFD者。
要点
- CSFD组VTE发生率1.8%,非CSFD组3.5%,比值比0.70(95%CI 0.28-1.78,P=0.300)。
- 术后因脊髓缺血挽救治疗放置CSFD者VTE发生率9.1%,高于其他CSFD患者的1.1%(P=0.044)。
- 择期外手术者VTE比例95%,择期手术者为41%(P<0.001)。
核心结论
- CSFD放置与TEVAR/FEVAR患者VTE风险升高无关。
- 择期外手术及围术期经过复杂的患者VTE风险更高。
- 接受治疗性CSFD者VTE风险高于预防性CSFD者,作者据此强调预防性CSFD放置需谨慎选择患者。
研究设计与样本
- 单中心连续TEVAR/FEVAR患者回顾性分析,时间范围为2011—2020年,共897例。
- CSFD按术者偏好术前放置,或术后用于脊髓缺血挽救治疗。
- 主要终点为术后30天内影像学确诊的新发深静脉血栓或肺栓塞,未行常规术后VTE筛查。
- 比较有无VTE患者及有无CSFD患者,并采用逻辑回归探索VTE发生与CSFD暴露的关联。
主要发现
- 43%(387例)在诊疗过程中曾接受CSFD,其中术前94%(365/387)、术后脊髓缺血挽救治疗6%(22/387)。
- CSFD患者既往主动脉手术比例44% vs 37%(P=0.028),术后血制品用量780 vs 405 mL(P=0.005)。
- 总体VTE发生率2.2%(20例);其中深静脉血栓70%(14例)、肺栓塞50%(10例)、两者兼有20%(4例);有VTE者中65%(13例)有症状。
- 90%(18例)的VTE在住院期间发现,诊断中位时间为术后12.5天(四分位距7.5-18天)。
- 有VTE者择期外手术比例95% vs 41%(P<0.001),美国麻醉医师学会分级4.1 vs 3.7(P<0.001),重症监护住院时间24 vs 12天(P<0.001),血制品用量1,386 vs 559 mL(P<0.001)。
关键数值与推荐
- CSFD组VTE发生率1.8%,非CSFD组3.5%,比值比0.70(95%CI 0.28-1.78,P=0.300)。
- 术后因脊髓缺血挽救治疗放置CSFD者VTE发生率9.1%,其他CSFD患者为1.1%(P=0.044)。
临床怎么用
- 作者认为,CSFD放置未增加TEVAR/FEVAR术后VTE风险;预防性CSFD放置需谨慎选择患者。
- 作者指出,择期外手术及围术期经过复杂者VTE风险更高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Venous thromboembolism (VTE) incidence after thoracic and fenestrated endovascular aortic repair (TEVAR/FEVAR) is high (up to 6-7%) relative to other vascular procedures; however, the etiology for this discrepancy remains unknown. Notably, patients undergoing TEVAR/FEVAR commonly receive cerebrospinal fluid drains (CSFDs) for neuroprotection, requiring interruption of perioperative anticoagulation and prolonged immobility. We hypothesized that CSFDs are a risk factor for VTE after TEVAR/FEVAR. METHODS: Consecutive TEVAR/FEVAR patients at a single center were reviewed (2011-2020). Cerebrospinal fluid drains (CSFDs) were placed based on surgeon preference preoperatively or for spinal cord ischemia (SCI) rescue therapy postoperatively. The primary end-point was VTE occurrence, defined as any new deep venous thrombosis (DVT) or pulmonary embolism (PE) confirmed on imaging within 30 days postoperatively. Routine postoperative VTE screening was not performed. Patients with and without VTE, and subjects with and without CSFDs were compared. Logistic regression was used to explore associations between VTE incidence and CSFD exposure. RESULTS: Eight hundred ninety-seven patients underwent TEVAR/FEVAR and 43% (n = 387) received a CSFD at some point during their care (preoperative: 94% [n = 365/387]; postoperative SCI rescue therapy: 6% [n = 22/387]). CSFD patients were more likely to have previous aortic surgery (44% vs. 37%; P = 0.028) and received more postoperative blood products (780 vs. 405 mL; P = 0.005). The overall VTE incidence was 2.2% (n = 20). 70% (14) patients with VTE had DVT, 50% (10) had PE, and 20% (4) had DVT and PE. Among TEVAR/FEVAR patients with VTE, 65% (n = 13) were symptomatic. Most VTEs (90%, n = 18) were identified inhospital and the median time to diagnosis was 12.5 (interquartile range 7.5-18) days postoperatively. Patients with VTE were more likely to have nonelective surgery (95% vs. 41%; P < 0.001), had higher American Society of Anesthesiologists classification (4.1 vs. 3.7; P < 0.001), required longer intensive care unit admission (24 vs. 12 days; P < 0.001), and received more blood products (1,386 vs. 559 mL; P < 0.001). Venous thromboembolism (VTE) incidence was 1.8% in CSFD patients compared to 3.5% in non-CSFD patients (odds ratio 0.70 [95% confidence interval 0.28-1.78, P = 0.300). However, patients receiving CSFDs postoperatively for SCI rescue therapy had significantly greater VTE incidence (9.1% vs. 1.1%; P = 0.044). CONCLUSIONS: CSFD placement was not associated with an increased risk of VTE in patients undergoing TEVAR/FEVAR. Venous thromboembolism (VTE) risk was greater in patients undergoing nonelective surgery and those with complicated perioperative courses. Venous thromboembolism (VTE) risk was greater in patients receiving therapeutic CSFDs compared to prophylactic CSFDs, highlighting the importance of careful patient selection for prophylactic CSFD placement.
引用
- Fazzone B, Anderson EM, Krebs J, et al. Perioperative Cerebrospinal Fluid Drain Placement Does Not Increase Venous Thromboembolism Risk After Thoracic and Fenestrated Endovascular Aortic Repair. Ann Vasc Surg. 2023. PMID: 37972728. doi:10.1016/j.avsg.2023.09.079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。